Joe DePinto, MBA, of McKesson; Kathi Henson, MBA, of Orsini; and Natalie Bedford of McKesson discuss how Asembia's AXS25 ...

High costs and the novelty and complexity of new therapies such as gene therapy present social determinants of health and ...

A growing and more diverse pipeline means that there is a greater need for digital innovations, which can address ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast for the fourth time, betting on strong demand for costly specialty medicines and branded drugs.